Emcure Pharmaceuticals consolidated net profit rises 25.13% in the September 2025 quarter
(11 Nov 2025)

Back
Net profit of Emcure Pharmaceuticals rose 25.13% to Rs 243.46 crore in the quarter ended September 2025 as against Rs 194.57 crore during the previous quarter ended September 2024. Sales rose 13.38% to Rs 2269.82 crore in the quarter ended September 2025 as against Rs 2001.98 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales2269.822001.98 13
OPM %20.9519.03 -
PBDT446.06370.31 20
PBT341.42273.41 25
NP243.46194.57 25

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew